Why it was recalled
Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits
Product description
Fentanyl Transdermal System. 75 mcg/h, packaged in 5 pouch system (NDC 0591-3213-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3213-54.
Lot numbers, UPCs & expiration codes
Lot #: 1107745A, Exp. Mar 2018;1122452A, 1137109A, Exp. Jun 2018; 1144515A, Exp. Oct 2018; 1189477A, Exp. Mar 2019; 1215224A, Exp. Aug 2019.
Where it was sold
Distributed nationwide within the United States
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0542-2018
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jan 29, 2018
- FDA report date
- Feb 14, 2018
- Quantity
- 576, 760 (5 pouches/carton)
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Teva Pharmaceuticals USA
Original FDA data
Every field from FDA enforcement report D-0542-2018, exactly as published.
Show all FDA fields
- City
- North Wales
- State
- PA
- Status
- Terminated
- Country
- United States
- Event ID
- 79062
- Address
- 1090 Horsham Rd
- Code information
- Lot #: 1107745A, Exp. Mar 2018;1122452A, 1137109A, Exp. Jun 2018; 1144515A, Exp. Oct 2018; 1189477A, Exp. Mar 2019; 1215224A, Exp. Aug 2019.
- Postal code
- 19454-1505
- Report date
- Feb 14, 2018
- Product type
- Drugs
- Recall number
- D-0542-2018
- Classification
- Class III
- Recalling firm
- Teva Pharmaceuticals USA
- Product quantity
- 576, 760 (5 pouches/carton)
- Termination date
- Sep 5, 2018
- Reason for recall
- Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Fentanyl Transdermal System. 75 mcg/h, packaged in 5 pouch system (NDC 0591-3213-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3213-54.
- Distribution pattern
- Distributed nationwide within the United States
- Recall initiation date
- Jan 29, 2018
- Initial firm notification
- Letter
- Center classification date
- Feb 22, 2018